港股異動丨蘋果概念股普漲 蘋果三季度業績好於預期
格隆匯10月31日丨蘋果概念股普漲,其中瑞聲科技(2018.HK)漲3.65%,比亞迪電子(0285.HK)漲近2%。

蘋果公司週三美股盤後公佈了好於預期的2019財年第四財季報告,盤後股價漲近2%。財報數據顯示,截至2019年9月28日,蘋果當季實行營收640億美元,較去年同期增長近2%,高於市場預期的630.1億美元。每股收益為3.03美元,同比增長近4%,也高於預期的2.84美元。iPhone當季實現營收333.62億美元,好於預期的324.2億美元。當季蘋果在中國市場營收微幅下滑,止住了之前的頹勢。庫克在財報電話會議上表示,目前iPhone 11 和 iPhone 11 Pro/Max的銷量表現十分喜人。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.